Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

JAMA Study, Editorial Caution Routine Use Of MRI To Detect Breast Cancer

This article was originally published in The Gray Sheet

Executive Summary

Future studies need to establish whether MRI as a breast cancer detection tool corresponds with reductions in mortality before it is applied broadly to at-risk patients, a JAMA study and accompanying editorial conclude

You may also be interested in...



MRI Shows High Sensitivity In Breast Cancer Detection – NCI-Funded Study

Magnetic resonance imaging, unlike mammography, appears to offer high sensitivity for women with dense breasts, according to a study published in the Dec. 8 issue of the Journal of the American Medical Association

MRI Shows High Sensitivity In Breast Cancer Detection – NCI-Funded Study

Magnetic resonance imaging, unlike mammography, appears to offer high sensitivity for women with dense breasts, according to a study published in the Dec. 8 issue of the Journal of the American Medical Association

MRI Sensitivity Over 30% Higher Than Mammography – NEJM Study

Magnetic resonance imaging can detect tumors in women at high-risk for breast cancer at a greater rate than mammography, but has a lower specificity, according to a New England Journal of Medicine study

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel